Brief: Scopus Biopharma Issues Open Letter To Stockholders
17/12/2021 13:05
Dec 17 (Reuters) - Scopus Biopharma Inc SCPS.O :
* SCOPUS BIOPHARMA ISSUES OPEN LETTER TO STOCKHOLDERS
* SCOPUS BIOPHARMA INC - COMPANY URGES STOCKHOLDERS TO VOTE
"FOR
ALL" OF CO'S DIRECTOR NOMINEES ON WHITE PROXY CARD
* SCOPUS BIOPHARMA SAYS MORRIS C. LASTER, M.D. CONTINUES HIS
CAMPAIGN TO ELECT TWO INDIVIDUALS
Source text for Eikon: ID:nGNXbVXmsC
Further company coverage: SCPS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scopus Biopharma
See all newsBrief: Scopus Biopharma - Nasdaq Hearings Panel Informed Company, By Letter Dated December 15, Of Its Determination To Delist Co's Common Stock From Nasdaq
Brief: Scopus Biopharma Completes Recapitalization To Enhance Shareholder Value
Brief: Scopus Biopharma Says Received Additional Non-Compliance Letter From Nasdaq
Brief: Scopus Biopharma Received Deficiency Letter From Nasdaq
Brief: Scopus BioPharma Inc- On April 4, Received Deficiency Notification Letter From Nasdaq Indicating Co Was Not In Compliance With Nasdaq Listing Rule